Evidence map›Paper›PMID 41471772›Full record

ReviewMolecules (Basel, Switzerland)2025

Co-Reactant Engineering for Au Nanocluster Electrochemiluminescence.

Nguyen Phuc An Khang, Joohoon Kim

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Nguyen Phuc An KhangDepartment of Chemistry, Research Institute for Basic Science, Kyung Hee University, Seoul 02447, Republic of Korea.ORCID 0009-0001-4494-0657
Joohoon KimDepartment of Chemistry, Research Institute for Basic Science, Kyung Hee University, Seoul 02447, Republic of Korea.ORCID 0000-0003-1481-2440

Funding

National Research Foundation of Korea RS-2025-00560034
6 · The paper itself

Abstract

Co-reactants are essential in co-reactant-based electrochemiluminescence (ECL) systems because they generate reactive intermediates that can oxidize or reduce ECL luminophores, thereby driving ECL emission. In the context of ECL, gold nanoclusters (Au NCs) have emerged as innovative luminophores, owing to their tunable electronic structures and excellent biocompatibility. However, their efficiency in ECL applications is often compromised by challenges such as limited excited-state generation and non-radiative losses. To tackle these practical challenges, advanced co-reactant engineering strategies have been developed to improve the performance of Au NCs in ECL systems. This review begins with a brief overview of the mechanisms of ECL. Subsequently, a systematic overview of various co-reactant engineering strategies is presented, including: (1) using innovative co-reactants to replace traditional ones due to their lower toxicity and better biocompatibility; (2) applying co-reaction accelerators to reduce the onset potential and improve the production of reactive intermediates from co-reactants; (3) combining co-reactants with luminophores or creating integrated nanostructure assemblies of co-reactants, co-reaction accelerators, and luminophores to achieve shorter electron transfer paths and reduced energy loss for stable high-intensity ECL emission; (4) utilizing host-guest strategies that encapsulate co-reactants within cavities to stabilize radical intermediates and minimize environmental quenching. This review provides a comprehensive overview of recent developments in co-reactant engineering for Au NCs-based ECL systems, thereby encouraging further exploration and understanding of these systems and expanding their potential applications.

Indexed as

co-reactant engineering strategyco-reactantselectrochemiluminescencegold nanoclusters

Identifiers

PMID41471772
PMCPMC12736278

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.